CD4 and ductal breast carcinoma in situ: To test whether the colocalisation pattern in adjacent DCIS differs according to T cell subsets, we evaluated the quantitative number, ratio and DCIS immune colocalisation using CD4, CD8 and FOXP3 cells in the IHC dataset of adjacent tumours (Fig. 7a).